Parma, Italy

Raimondo Maggi

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Endura Spa. Active years: 2010.

USPTO Granted Patents = 1 


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raimondo Maggi: Innovator in Catalytic Synthesis

Introduction

Raimondo Maggi is a notable inventor based in Parma, Italy. He has made significant contributions to the field of chemistry, particularly in the development of catalysts for the synthesis of optically active compounds. His work is characterized by a focus on innovative solutions that enhance chemical processes.

Latest Patents

Raimondo Maggi holds a patent for "Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid." This patent describes catalysts derived from optically active compounds, specifically bisoxazolines and salicylaldimines, which are supported on organic or inorganic matrices. These catalysts are particularly employed in the synthesis of optically active chrysanthemic acid, showcasing his expertise in the field.

Career Highlights

Raimondo Maggi is associated with Endura Spa, where he applies his knowledge and skills in chemical synthesis. His work at the company reflects his commitment to advancing the field of catalysis and contributing to innovative chemical solutions.

Collaborations

Throughout his career, Raimondo has collaborated with talented individuals such as Giada Tanzi and Valerio Borzatta. These collaborations have likely enriched his research and development efforts, fostering a creative environment for innovation.

Conclusion

Raimondo Maggi's contributions to the field of chemistry, particularly through his patented work on catalysts, highlight his role as an influential inventor. His dedication to advancing chemical synthesis continues to inspire innovation in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…